NEWS
Our Latest News
ARCHIMED buys Denmark’s DermaPharm A/S, a leading developer and manufacturer of skincare products
Global private equity healthcare specialist ARCHIMED announces the acquisition of DermaPharm A/V. DermaPharm is a leading player in Nordic suncare and a world-renowned skincare contract development & manufacturing organization for third parties.
ARCHIMED buys Denmark’s DermaPharm A/S, a leading developer and manufacturer of skincare products
October
15,
2025
ARCHIMED acquires cell line development pioneer ExcellGene to accelerate expansion into biosimilars and high-performance transfection solutions
September
25,
2025
ARCHIMED acquires generative AI Diagnostics player Arkstone to support fight against infectious disease
August
1,
2025
ARCHIMED’s MED II sells DIESSE, returning 4.6x to shareholders
January
27,
2025
368